HOME >> MEDICINE >> NEWS
NIH convenes panel to assess evidence on chronic insomnia

The National Institutes of Health (NIH) will hold a State-of-the-Science Conference on the Manifestations and Management of Chronic Insomnia in Adults on June 13-15, 2005, at the Natcher Conference Center, on the NIH campus in Bethesda, MD. A press briefing will be held at the close of the conference, at 2:00 p.m. on Wednesday, June 15.

During the first day and part of the second day of the conference, experts will present the latest findings in the research of chronic insomnia to an independent panel. The panel will then meet in executive session to weigh the available scientific evidence and prepare its statement assessing the state of the science, to be presented for public comment at 9:00 a.m. on Wednesday, June 15.

Insomnia is the most common sleep complaint reported by women and men across all stages of adulthood and for many, the problem is chronic. While insomnia often exists simultaneously with other medical conditions (co-morbidities), the definitive etiology (cause) of insomnia remains unknown. Nevertheless, chronic insomnia is associated with a wide range of adverse consequences (morbidities), including depression, alcohol and drug abuse, difficulties with concentration and memory, and various cardiovascular, pulmonary, and gastrointestinal disorders. In addition to reduced quality of life and increased health care use reported by insomnia sufferers, the large number of people experiencing insomnia ultimately results in significant economic burden to society in lost productivity and health care costs. Although a number of promising behavioral and pharmacological approaches have recently been identified for the management of chronic insomnia symptoms, there has been limited guidance for clinicians in terms of choice of treatment.

The panel's statement will address these five key questions:

  • How is chronic insomnia defined, diagnosed, and classified, and what is known about its etiology?
  • What are the prevalenc
    '"/>


Contact: OMAR Information Center
nihcdp@mail.nih.gov
888-644-2667
NIH/Office of the Director
3-Jun-2005


Page: 1 2 3

Related medicine news :

1. American College of Physicians Foundation convenes conference
2. New Orleans levee report finished by panel including University of Texas at Austin engineer
3. IOF and EU panel prepare osteoporosis audit
4. RAND panel identifies key components of public health emergency preparedness
5. Medical, IT, engineering experts form advisory panel for electronic health record safety
6. SCAI expert panel sets high standards for PCI without on-site cardiac surgical backup
7. Conference on health communication call for papers and panel proposals
8. Consensus panel calls for expanded role of needle biopsies, MRI and less invasive procedures
9. Independent panel to evaluate a chemical used in some plastics for hazards to human health
10. Children need 60 minutes of daily physical activity, expert panel says
11. Children need 60 minutes of daily physical activity, expert panel says

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NIH convenes panel assess evidence chronic insomnia

(Date:4/1/2015)... Peoria, Ill. (PRWEB) April 01, 2015 ... the OSF Healthcare System , was welcomed into ... Dedication Ceremony officiated by Msgr. Paul E. Showalter, vicar ... , The Blessing and Dedication culminated a nearly year-long ... the eleventh OSF HealthCare hospital. Speakers for the morning ...
(Date:4/1/2015)... CA (PRWEB) April 01, 2015 ... senior care, today announces the launch of the ... innovative senior care stakeholders and technology companies. The announcement ... Center (NIC) Capital and Business Strategies Forum in ... members, the new Alliance program is now open for ...
(Date:4/1/2015)... Dr. Rod J. Rohrich , Dallas ... Department of Plastic Surgery at UT Southwestern Medical Center, ... blindness resulting from the use of facial aesthetic ... study, along with ideas for treatment and prevention in ... to see increasing reports of blindness as a result ...
(Date:4/1/2015)... GA (PRWEB) April 01, 2015 ... Medicine Practice, Pediatric Emergency Medicine Practice, and Hospital ... has partnered with AgileMD to provide the content ... , in a mobile application format available on ... , “Our collaboration with AgileMD to develop mobile ...
(Date:4/1/2015)... 2015 Skin cancer is one of the ... caught early. Forefront Dermatology and Dermatology Associates of Wisconsin want ... before it spreads so they are hosting a free skin ... 8:30am - 12:30pm. , “If we can see the ... concern, that could become cancerous,” said Dr. Ken Katz, who ...
Breaking Medicine News(10 mins):Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 2Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 4Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 3Health News:EB Medicine Partners With AgileMD on Mobile Application for Emergency Medicine Clinicians 2Health News:EB Medicine Partners With AgileMD on Mobile Application for Emergency Medicine Clinicians 3Health News:Forefront Dermatology and Dermatology Associates of Wisconsin Offers Skin Cancer Screenings on April 11th 2
(Date:4/1/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/kz78wm/medical_device ) ... Device Studies: Clinical Evidence" conference to their ... specifically for those who are involved in gathering ... diagnostic products. Clinical data is required for all ... appropriate clinical evidence has grown substantially in the ...
(Date:4/1/2015)... Md. , April 1, 2015  RegeneRx ... today announced that a new medical paper has ... beta 4 (TB4) in patients with severe dry ... the study and the physicians stated that statistically ... severe dry eye were seen at various time ...
(Date:4/1/2015)... LAVAL, Quebec , April 1, ... Inc. (NYSE: VRX and ... completed the previously announced acquisition of ... a specialty pharmaceutical company that offers ...  (rifaximin) 550 mg, RUCONEST ®  (C1 esterase inhibitor ...
Breaking Medicine Technology:Medical Device Studies: Clinical Evidence Seminar - London, UK, 13th, 14th of May 2015 2RegeneRx's RGN-259 Meets Key Efficacy Objectives in Phase 2 Clinical Trial in Patients with Severe Dry Eye Reported in Current Issue of Cornea 2RegeneRx's RGN-259 Meets Key Efficacy Objectives in Phase 2 Clinical Trial in Patients with Severe Dry Eye Reported in Current Issue of Cornea 3
Cached News: